高级检索
    吴世凯, 宋三泰, 张国淳. 术后高危乳腺癌HDC+AHSCT辅助治疗的地位评价[J]. 循证医学, 2005, 5(1): 8-11. DOI: 10.3969/j.issn.1671-5144.2005.01.003
    引用本文: 吴世凯, 宋三泰, 张国淳. 术后高危乳腺癌HDC+AHSCT辅助治疗的地位评价[J]. 循证医学, 2005, 5(1): 8-11. DOI: 10.3969/j.issn.1671-5144.2005.01.003
    shu
    WU Shi-kai, SONG San-tai, ZHANG Guo-chun. Evaluation for the Role of Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation (HDC+AHSCT) in High-Risk Breast Cancer[J]. Journal of Evidence-Based Medicine, 2005, 5(1): 8-11. DOI: 10.3969/j.issn.1671-5144.2005.01.003
    Citation: WU Shi-kai, SONG San-tai, ZHANG Guo-chun. Evaluation for the Role of Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation (HDC+AHSCT) in High-Risk Breast Cancer[J]. Journal of Evidence-Based Medicine, 2005, 5(1): 8-11. DOI: 10.3969/j.issn.1671-5144.2005.01.003
    shu

    术后高危乳腺癌HDC+AHSCT辅助治疗的地位评价

    Evaluation for the Role of Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation (HDC+AHSCT) in High-Risk Breast Cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回